After 20 years in cataract care, I have to be honest about the one test almost no one runs before your operation.
Independent eye-health reporting Questions? support@theocularreview.com
The Ocular Review
Independent Eye-Health Investigations Since 1998
Home Eye Health Cataract Surgery The pre-surgery test almost no one runs

After 20 years in cataract care, I have to be honest about the one test almost no one runs before your operation.

It takes about 60 seconds. It isn't on the standard checklist. And whether it quietly gets done can decide whether you spend the months after your surgery seeing clearly — or wishing you could keep your eyes closed. Here's what I tell every patient to do in the weeks before.

Medically reviewed by [Reviewing physician, MD]
An optometrist at her desk in a consulting room
"I left full-time practice partly so I could say this plainly."  ·  The Ocular Review

For 20 years I co-managed cataract patients. I ran the pre-operative workups. I sat with people the week before their surgery, and I saw them again in the weeks after. Thousands of eyes. Hundreds of dry-eye assessments.

And there is a pattern I watched repeat so many times that I eventually stepped back from full-time practice partly so I could say this plainly, without an employer's letterhead over my shoulder.

Patients would walk out of surgery delighted — the cataract gone, the world bright and sharp again — and come back 6 weeks later barely able to keep their eyes open.

I want to tell you exactly why that happens, why almost no one is warned about it, and what I came to tell every patient to do in the short window beforehand. Because in most of those cases, it did not have to happen at all.

The pattern I watched repeat for 20 years

They described it the same way, almost word for word.

Burning by mid-afternoon. A gritty, sandy feeling, like there was something under the lid. Eyes that watered constantly and yet still felt bone dry — a contradiction that makes perfect sense once you understand the mechanism, and none at all before. The vision itself was often excellent. The cataract was gone. And they were miserable, sometimes for months.

Here is the part that kept me up at night. In a great many of those cases, I could have told you it was coming. Before the surgery. From a quick look at the surface of the eye that takes about 60 seconds — and that most of those patients never received.

"They'd come back 6 weeks later barely able to keep their eyes open. And in most cases, I could have predicted it before they ever went in."

— Dr. Helen Cartwright, OD

I want to be careful and fair here. This is not about a surgeon doing a bad job. The surgeries were, by and large, excellent. The lens goes in, the cataract comes out, the vision is restored. By every measure the operation is judged on, it succeeds.

The problem is that the part of the eye that decides how you feel afterward — and, as you'll see, partly how well you see — is not the part the surgery is built around. And the test that would flag it is not on the standard list.

The 60-second test almost no one runs

Meibography scan showing comb-like oil glands with dropout gaps
A 60-second gland scan — and the gaps most patients are never shown  ·  The Ocular Review

Along the rim of each eyelid sits a row of tiny glands. Their entire job is to release a thin layer of oil onto your tears — the oil that stops your tears evaporating before your next blink. When those glands underperform, the oil layer thins, the tear film breaks apart too fast, and the surface of the eye dries, burns, and inflames. The clinical name is meibomian gland dysfunction. You don't need the name. You need to know it is extremely common, it advances quietly for years, and most people have no idea they have it until something forces the issue.

That something is very often surgery.

There are simple ways to see this before an operation. A close look at the gland openings. A dye that shows how fast the tear film breaks up. On the better-equipped days, an actual scan of the glands themselves, where you can see the gaps where glands have shut down. None of it takes long.

So why is it so often skipped? I'll be honest with you, because I worked inside it. The cataract pathway is built for volume and for the cataract. The pre-op appointment is largely about measuring the eye for the new lens and clearing you as fit for surgery. A full tear-film and gland assessment isn't formally required to proceed, it takes extra chair time, and when a clinic is moving a high volume of patients through, the things that aren't required are the things that quietly fall off. Not out of malice. Out of throughput.

The result is that an enormous number of people walk into cataract surgery with glands that were already struggling — and nobody looked.

What the research shows

In studies of patients scheduled for routine cataract surgery, a striking share — more than half in several series, and the majority in some — already showed measurable tear-film or meibomian gland abnormalities before the operation. A large proportion had no symptoms they'd have mentioned. The problem is usually there first. The surgery reveals and amplifies it.

Why this one is permanent — the measurement and the lens

If this were only about comfort, I'd still want you to know. But it isn't only about comfort, and this is the part I most want you to understand, because it cannot be undone afterward.

To choose the artificial lens that goes inside your eye, the surgeon takes a precise measurement of the eye's optics. A meaningful part of that measurement is read across the front surface of your eye — across the tear film. If that surface is smooth and stable, the measurement is reliable. If it's broken up and unstable on the day, the measurement can come out slightly off.

And the lens chosen from that measurement is permanent. It stays in your eye for the rest of your life.

So an unstable tear film at the time of measuring isn't a small thing. It can mean a lens chosen from an unreliable number — a result that's a little off, in a way no drop afterward can correct. On top of that, the surgery itself disturbs the nerves on the eye's surface, the ones that tell your eye to make tears and to blink. That's why the dryness so often spikes for weeks or months after. The surgery adds a second hit to a surface that was already, in many people, quietly running low.

Three problems, one cause, one window

Comfort: a struggling oil layer means months of burning and grit after surgery.

The result itself: an unstable surface at measurement can mean a permanent lens chosen from an unreliable number.

The amplifier: surgery disturbs the surface nerves, making a borderline surface markedly worse for weeks.

All three trace back to the same surface — and there's a short window beforehand when that surface can actually be supported.

Every option I've seen tried, and where each one stops

Over 20 years I prescribed or recommended nearly everything on this list. I'm not here to run any of it down — these are legitimate tools and I still use them. I want to tell you honestly what each one does, and the exact point at which it stops, because once you see the pattern you'll understand why so many people do everything "right" and still end up where they started.

Option

Lubricating drops

The first thing everyone reaches for, and a reasonable one. They give real relief.

Where they stop: Drops sit on the surface. They top up the watery layer for a few minutes, then evaporate. They never reach the glands beneath the lid — and the glands are where the missing oil is made. You can't drip your way down to them.
Option

Warm compresses and lid hygiene

Genuinely useful, and something I recommend. They warm and soften what's blocking the gland openings.

Where they stop: A compress works at the opening of the gland from the outside. It can't rebuild the quality of the oil the gland produces, and in practice almost no one keeps it up daily for the weeks it would take to matter. I've watched the compliance fall away for 20 years.
Option

Prescription anti-inflammatory drops

Appropriate in the right cases, and they can quiet an angry surface.

Where they stop: They calm inflammation at the surface, which is real and worth having. But they don't address what's driving the inflammation — the gland function slowly failing underneath. Quiet the smoke; the fire keeps smouldering.
Option

A bottle of standard fish oil

Someone almost always suggests it, and the instinct is right — the fats in fish oil genuinely matter to the oil layer.

Where they stop: Fish oil isn't wrong, it's incomplete. The oily seal is only one of several things going wrong at once — there's also the inflammation around the glands, the oxidative stress on the surface, and the health of the gland tissue itself. A single capsule aimed at one piece was never going to move a problem with several moving parts.

Do you see it? Every one of these works at the surface, or addresses a single piece. Not one of them reaches the cause, in the place the cause actually lives, in a way that covers the whole problem at once. For 20 years I handed people pieces of a solution and watched them wonder why the pieces never added up.

What actually reaches the glands

Tear-film cross-section diagram: the oil layer intact versus failing
The oil layer — intact, and breaking up  ·  The Ocular Review

Here is the simple physiological fact that reframes the whole thing. The glands are living tissue. They are fed by your bloodstream — not by anything you put on the surface of the eye. So the only route that genuinely reaches them, that can support the quality of the oil they make and the health of the tissue itself, is internal. From the inside, carried by the circulation, over a matter of weeks.

That isn't an exotic claim. It's basic plumbing, and any clinician will confirm it if you ask. But it runs against the entire commercial habit of dry-eye care, which is built almost entirely on things you apply to the surface. I spent two decades inside a system that mostly handed people surface tools for a problem rooted in tissue underneath.

When patients finally understood that, the next question was always the same: then what does reach them? And that's the question that matters, because the answer has to do more than one job at once.

What I now tell every patient to do before surgery

Four-Lane Tear-Shield diagram: oil seal, inflammation, all three tear layers and eye tissue converging on one stable tear film
Four lanes, one tear film — why single-ingredient fixes fall short  ·  The Ocular Review

What I look for now — and what I point my own patients toward — is internal support built for the whole problem, not one corner of it. In practice that means four things working together, because the surface, the inflammation, the tear film, and the gland tissue tend to struggle together.

Lane 1 — the oil seal

Omega-3 fats (EPA and DHA) supply the building blocks for the oily layer the glands are meant to produce — the layer that slows evaporation. Not as a megadose of fish oil, but as one structural part of a system.

Lane 2 — the inflammation around the glands

Astaxanthin, vitamin C, natural vitamin E and CoQ10 help calm the oxidative and inflammatory stress that keeps the dryness loop turning — so the surface has a chance to settle instead of feeding itself.

Lane 3 — the whole tear film, all three layers

Alpha-lipoic acid is unusual: it's both fat- and water-soluble, which means it's one of the few antioxidants that can reach all three layers of the tear film, the oily and the watery alike. Most reach only one. This one reaches across.

Lane 4 — the gland tissue itself

Lutein and zeaxanthin are the pigments eye tissue concentrates and uses, with zinc to support normal eye-health function — supporting the resilience of the surface the other three lanes work on.

Covering all four, from the inside, over the weeks before surgery — that is the version of "preparing your eyes" that I almost never saw done, and the one I wish every patient had been offered. The formula I now point people to is built on exactly this four-part approach. It's called Norella.

To show you what that looks like in practice, here is a case I saw more times than I can count.

An older patient at the slit-lamp during a brief eye exam
The look that takes about a minute — and so often doesn't happen  ·  The Ocular Review
Representative Case · From Practice Illustrative composite

Patient profile: Woman, early 60s. Booked for routine cataract surgery. Mentioned, almost in passing, that her eyes felt "gritty by the afternoon" — something she'd blamed on screens and age for 2 years and never thought to raise.

On assessment: Clear, unmentioned meibomian gland changes and a fast tear-film break-up. Asymptomatic enough that, without the look, she'd have proceeded straight to surgery.

What changed: Roughly 5 weeks of internal, four-lane support before the operation. By her surgery date the surface measured stable; by her post-op reviews she did not develop the prolonged dryness so common in patients who walk in unprepared.

Details are a composite of common presentations and are illustrative, not a single identified patient. Individual results vary.

The window — and why it closes the day they measure your eye

This is the part that makes it urgent, and I want to be precise about it rather than dramatic.

The glands respond slowly. We're talking weeks, not days. So support that's started the week of surgery — or, as most people do it, after surgery once the misery has already arrived — has largely missed the moment that mattered. The leverage is in the weeks before, while there's still time for the surface to settle ahead of the measurement and the operation.

Once they measure your eye and choose your lens, that particular door has closed. The lens is selected. You can still chase comfort afterward, and you should — but the chance to walk in with a more stable surface, and a more reliable measurement, is gone.

So if you have a surgery date, you are in the window right now. That's not a sales line. It's just the biology of how long these glands take to respond, set against a fixed date on your calendar.

"In 20 years I never understood why a patient wouldn't prepare the surface first. A few weeks of support, refundable if it does nothing — against a permanent lens and months you can't get back. As a clinician, that was never a close call."

— Dr. Helen Cartwright, OD
Where to find the formula referenced above

Dr. Cartwright references a four-lane internal formula throughout this article. For readers asking where to find it, it is sold directly by the maker below. The Ocular Review may receive a commission from this paid partnership; it does not affect the price you pay.

Norella · Oil Seal Formula
90 Softgels  ·  90-Day Supply  ·  For adults 40+
  • Internal support — reaches the glands drops can't
  • Lane 1 · Omega-3 oil seal
  • Lane 2 · Astaxanthin, C, E, CoQ10 — inflammation
  • Lane 3 · Alpha-lipoic acid — all 3 tear layers
  • Lane 4 · Lutein, zeaxanthin, zinc — eye tissue
  • Hormone-free · works alongside your drops
  • 90-day money-back guarantee
See Norella before your date · shopnorella.com
90-day money-back guarantee  ·  If it does nothing for you, you pay nothing  ·  Free shipping

A practical note from the article: because the glands respond over weeks, the only version of this that helps is the one started before your surgery. And as Dr. Cartwright puts it, the risk runs one way — a few weeks of support with every cent back if it does nothing, against a permanent lens measured off an unstable surface and the months of grit so many patients describe. Always tell your own surgeon and eye doctor what you're taking, and follow their guidance on your procedure.

These statements have not been evaluated by the Food and Drug Administration or equivalent authority. This product is not intended to diagnose, treat, cure, or prevent any disease, and is not a treatment for cataracts, dry eye disease, or any surgical outcome. It does not guarantee the accuracy of any surgical measurement or the result of any procedure, and does not replace the advice of your surgeon, optometrist, or physician — always follow their guidance. The author is an eye-care professional sharing general clinical perspective; this article is informational and is not personal medical advice, and does not establish a clinical relationship. The case described is an illustrative composite of common presentations, not a single identified patient. Individual results vary; accounts described here are not typical. This is a paid partnership between The Ocular Review and Norella.